Related Experiment Video

Updated: Aug 16, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Endocrine therapy for prostate cancer

F Labrie1

  • 1Department of Molecular Endocrinology, CHUL Research Center, Quebec, Canada.

Endocrinology and Metabolism Clinics of North America
|December 1, 1991
PubMed

Insights

Advanced prostate cancer treatment is improved by blocking androgen receptors and using castration. This combination therapy, including antiandrogens and luteinizing hormone-releasing hormone agonists, prolongs patient response duration and survival.

Area of Science:

  • Endocrinology
  • Oncology
  • Cancer Biology

Background:

  • Prostate cancer is the most common cancer affecting men globally.
  • Testes produce 60% of adult male androgens, with the remaining 40% synthesized in peripheral tissues like the prostate from adrenal precursors.
  • This highlights the role of peripheral androgen synthesis in prostate cancer progression.

Purpose of the Study:

  • To investigate the efficacy of a combination therapy for advanced prostate cancer.
  • To evaluate the impact of androgen receptor blockade and castration on treatment outcomes.

Main Methods:

  • Utilizing a combination therapy involving a pure androgen receptor blocker (antiandrogen) and castration (medical via luteinizing hormone-releasing hormone agonist or surgical orchiectomy).

Main Results:

  • Demonstrated a significant prolongation in the duration of response for patients with advanced prostate cancer.
  • Showed a statistically significant improvement in survival rates for the first time with this combined therapeutic approach.

Conclusions:

  • Combination therapy of antiandrogens and castration offers a novel and effective strategy for managing advanced prostate cancer.
  • This approach provides a new paradigm for improving treatment outcomes and extending survival in advanced prostate cancer patients.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.